Skip to main content
Cancer Cell International logoLink to Cancer Cell International
. 2024 Nov 11;24:375. doi: 10.1186/s12935-024-03566-0

Retraction Note: ZKSCAN3 drives tumor metastasis via integrin β4/FAK/AKT mediated epithelial-mesenchymal transition in hepatocellular carcinoma

Jieqiong Li 1, Nan Hao 2, Juan Han 3, Mi Zhang 4, Xiaomei Li 5,, Nan Yang 6,
PMCID: PMC11556177  PMID: 39529135

Retraction Note to: Cancer Cell International (2020) 20:216

10.1186/s12935-020-01307-7

The Editor in Chief has retracted this article because after publication it was noted that Fig. 6C has been previously published in another publication [1] and due to an overlap of the image in Fig. 2D with another publication [2]. The Editor in Chief has therefore lost confidence in the integrity of the results of this article.

Nan Yang has agreed to this retraction on behalf of all authors.

Footnotes

The online version of the original article can be found at 10.1186/s12935-020-01307-7.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Xiaomei Li, Email: 39251157@qq.com.

Nan Yang, Email: nan_yang@xjtufh.edu.cn.

References

  • 1.Xu Q, Liu X, Liu Z, et al. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway. Mol Cancer. 2017;16:103. 10.1186/s12943-017-0675-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Yao B, Li Y, Wang L, Chen T, Niu Y, Liu Q, Liu Z. MicroRNA-3194-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by decreasing Wnt/β-catenin signaling through targeting BCL9. Artif Cells Nanomed Biotechnol. 2019;47(1);3885–3895. 10.1080/21691401.2019.1670190. [DOI] [PubMed]

Articles from Cancer Cell International are provided here courtesy of BMC

RESOURCES